Evidence map›Paper›PMID 39890288›Full record

ReviewClinics in chest medicine2025

Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease.

Engi F Attia, Elizabeth Maleche-Obimbo, Laura E Ellington, Crystal M North

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in chest medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Engi F AttiaDivision of Pulmonary, Critical Care and Sleep Medicine, Departments of Medicine and Global Health, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: eattia@uw.edu.
Elizabeth Maleche-ObimboDepartment of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Laura E EllingtonDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle, WA, USA.
Crystal M NorthDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Funding

Mechanisms & risk factors of chronic lung disease in HIV+ adolescents in NairobiK23HL129888 · NHLBI · UNIVERSITY OF WASHINGTON · PI ATTIA, ENGI FAROUK · 2017 to 2021
$1.0M
NHLBI NIH HHS K23 HL129888
6 · The paper itself

Abstract

The spectrum of pulmonary disease in people with human immunodeficiency virus (PWH) across the lifespan has shifted from acute, infectious, and acquired immunodeficiency syndrome (AIDS)-defining illnesses to a greater burden of chronic, non-communicable processes. Here, the authors review the epidemiology and risk factors of pulmonary disease in PWH across the lifespan during the contemporary antiretroviral therapy era. The authors focus on recommendations for clinical care of pulmonary disease relevant to PWH, including emerging data from recent and ongoing clinical trials.

Indexed as

HIV InfectionsImmunocompromised HostLung DiseasesHumansRisk FactorsChronic pulmonary diseaseEpidemiologyHIVManagementPneumoniaRisk factorsTuberculosis

Identifiers

PMID39890288
PMCPMC12044705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.